Anti-integrin αvβ6 autoantibodies are a novel predictive biomarker in ulcerative colitis
A. E. Livanos, A. Dunn, J. Fischer, R. C. Ungaro, W. Turpin, S.-H. Lee, S. Rui, D. M. Del Valle, J. J. Julia, G. Martinez-Delgado, M. S. Riddle, J. A. Murray, R. M. Laird, J. Torres, M. Agrawal, , S. Mehandru
This study identifies anti-integrin αvβ6 autoantibodies as a predictive biomarker for ulcerative colitis, showing they precede diagnosis by up to 10 years and correlate with adverse outcomes.
bioRxiv · Nov 21, 2022 · PreprintImmunology